Skip to main content

Neutrophilic Dermatoses in Blood Disorders

  • Chapter
  • First Online:
Neutrophilic Dermatoses
  • 665 Accesses

Abstract

Neutrophilic dermatoses have long been associated with neoplastic blood disorders. As early as 1955, a 16-year-old patient with acute myeloid leukemia and recurrent cutaneous lesions including mature neutrophilic infiltrate was reported [1]. In 1973, 9 years after the seminal paper by Dr. Robert Douglas Sweet describing “acute febrile neutrophilic dermatosis”, proper Sweet syndrome was reported in two women as the presenting manifestation of their previously unsuspected acute myeloid leukemia [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Costello MJ, Canizares O, Montague M III, Buncke CM. Cutaneous manifestations of myelogenous leukemia. Arch Dermatol. 1955;71:605–14.

    Article  CAS  Google Scholar 

  2. Matta M, Lurban AK. Sweet’s syndrome: systemic association. Cutis. 1973;12:561–5.

    Google Scholar 

  3. Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, association and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69:557–64.

    Article  CAS  PubMed  Google Scholar 

  4. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol. 1988;6:1887–97.

    Article  CAS  PubMed  Google Scholar 

  5. Cohen PR, Kurzrock R. Sweet’s syndrome and cancer. Clin Dermatol. 1993;11:149–57.

    Article  CAS  PubMed  Google Scholar 

  6. Chevrant-Breton J, Logeais B, Pibouin M. Pyoderma gangrenosum (pyodermite phagédénique). Ann Dermatol Venereol. 1989;116:577–89.

    CAS  PubMed  Google Scholar 

  7. Szalat R, Monsel G, Le Goff W, Battistella M, Bengouffa D, Schlageter MH, et al. The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: association with IgA isotype and inflammatory profile. J Am Acad Dermatol. 2015;73:809–20.

    Article  CAS  PubMed  Google Scholar 

  8. Cohen PR. Sweet’s syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kazmi SM, Pemmaraju N, Patel KP, Cohen PR, Daver N, Tran KM, et al. Characteristics of Sweet syndrome in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015;15:358–63.

    Article  PubMed  Google Scholar 

  10. Alencar C, Abramowtiz M, Parekh S, Braunschweig I, Jacobson M, Silverman L, et al. Atypical presentations of Sweet’s syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors. Am J Hematol. 2009;84:688–9.

    Article  CAS  PubMed  Google Scholar 

  11. Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2017;18:355–72.

    Article  PubMed  Google Scholar 

  12. Bachmeyer C, Aractingi S. Neutrophilic eccrine hidradenitis. Clin Dermatol. 2000;18:319–30.

    Article  CAS  PubMed  Google Scholar 

  13. Fukutoku M, Shimizu S, Ogawa Y, Takeshita S, Masaki Y, Arai T, et al. Sweet’s syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anemia. Br J Haematol. 1994;84:645–8.

    Article  Google Scholar 

  14. Deasy AM, Walker B, Layton AM, Lacey CJ. Sweet’s syndrome in a patient with haemophilia, HIV, and hepatitis C infection. Int J STD AIDS. 2012;23:e11–3.

    Article  CAS  PubMed  Google Scholar 

  15. Mc Dermott MB, Corbally MT, O’Marcaigh AS. Extracutaneous Sweet syndrome involving the gastrointestinal tract in a patient with Fanconi anemia. J Pediatr Hematol Oncol. 2001;23:59–62.

    Article  CAS  Google Scholar 

  16. Chatham-Stephens K, Devere T, Guzman-Cottrill J, Kurre P. Metachronous manifestations of Sweet’s syndrome in a neutropenic patient with Fanconi anemia. Pediatr Blood Cancer. 2008;51:128–30.

    Article  PubMed  Google Scholar 

  17. Baron F, Sybert VP, Andrews RG. Cutaneous and extracutaneous neutrophilic infiltrates (Sweet syndrome) in three patients with Fanconi anemia. J Pediatr. 1989;115:726–9.

    Article  CAS  PubMed  Google Scholar 

  18. Saint-Jean M, Gagey-Caron V, Jossic F, Barbarot S, Hamidou M, Stalder JF. Amicrobial pustulosis of the skin folds and autoimmune erythroblastopenia. Ann Dermatol Venereol. 2011;138:399–404.

    Article  CAS  PubMed  Google Scholar 

  19. Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol. 2014;178:48–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Adachi Y, Kindzelskii AL, Cookingham G, Shaya S, Moore EC, Todd RF III, et al. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol. 1998;111:259–68.

    Article  CAS  PubMed  Google Scholar 

  21. Maalouf D, Battistella M, Bouaziz JD. Neutrophilic dermatosis: disease mechanism and treatment. Curr Opin Hematol. 2015;22:23–9.

    Article  CAS  PubMed  Google Scholar 

  22. Porneuf M, Duterque M, Sotto A, Jourdan J. Unusual erythema elevatum diutinum with fibrohistiocytic proliferation. Br J Dermatol. 1996;143:1131–4.

    Article  Google Scholar 

  23. Grob JJ, Mege JL, Capo C, Jancovicci E, Fournerie JR, Bongrand P, et al. Role of tumor necrosis factor-alpha in Sneddon-Wilkinson subcorneal pustular dermatosis. A model of neutrophil priming in vivo. J Am Acad Dermatol. 1991;25:944–7.

    Article  CAS  PubMed  Google Scholar 

  24. Van Loon K, Gill RM, McMahon P, Chigurupati R, Siddiqi I, Fox L, et al. 20q-clonality in a case of oral sweet syndrome and myelodysplasia. Am J Clin Pathol. 2012;137:310–5.

    Article  PubMed  Google Scholar 

  25. Van Kamp H, van den Berg E, Timens W, Kraaijenbrink RA, Halie MR, Daenen SM. Sweet’s syndrome in myeloid malignancy: a report of two cases. Br J Haematol. 1994;86:415–7.

    Article  PubMed  Google Scholar 

  26. Sujobert P, Cuccuini W, Vignon-Pennamen MD, Martin-Garcia N, Albertini AF, Uzunov M, et al. Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients. J Invest Dermatol. 2013;133(4):1111.

    Article  CAS  PubMed  Google Scholar 

  27. Chavan RN, Cappel MA, Ketterling RP, Wada DA, Rochet NM, Knudson R, et al. Histiocytoid Sweet syndrome may indicate leukemia cutis : a novel application of fluorescence in situ hybridization. J Am Acad Dermatol. 2014;70:1021–7.

    Article  PubMed  Google Scholar 

  28. Osio A, Battistella M, Feugeas JP, Cuccuini W, Noguera ME, Petrella T, et al. Myelodysplasis cutis versus leukemia cutis. J Invest Dermatol. 2015;135:2321–4.

    Article  CAS  PubMed  Google Scholar 

  29. Wallach D, Vignon-Pennamen MD. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol. 2006;55:1066–71.

    Article  PubMed  Google Scholar 

  30. Bielsa S, Baradad M, Marti RM, Casanova JM. Sweet’s syndrome with bullous lesions. Actas Dermosifiliogr. 2005;96:315–6.

    Article  PubMed  Google Scholar 

  31. Voelter-Mahlknecht S, Bauer J, Metzler G, Fierlbeck G, Rassner G. Bullous variant of Sweet’s syndrome. Int J Dermatol. 2005;44:946–7.

    Article  PubMed  Google Scholar 

  32. Kulasekararaj AG, Kordasti S, Basu T, Salisbury JR, Mufti GJ, du Vivier AWP. Chronic relapsing remitting Sweet syndrome – harbinger of myelodysplastic syndrome. Br J Haematol. 2015;170:649–56.

    Article  CAS  PubMed  Google Scholar 

  33. Vignon-Pennamen MD, Juillard C, Rybojad M, Wallach D, Daniel MT, Morel P, et al. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases. Arch Dermatol. 2006;142:1170–6.

    Article  PubMed  Google Scholar 

  34. Tomasini C, Aloi F, Osella-Abate S, Dapavo P, Pippione M. Immature myeloid precursors in chronic neutrophilic dermatosis associated with myelodysplastic syndrome. Am J Dermatopathol. 2000;22:429–33.

    Article  CAS  PubMed  Google Scholar 

  35. Deguchi M, Tsunoda T, Yuda F, Tagami H. Sweet’s syndrome in acute myelogenous leukemia showing dermal infiltration of leukemic cells. Dermatology. 1997;194:182–4.

    Article  CAS  PubMed  Google Scholar 

  36. Requena L, Kutzner H, Palmedo G, Pascual M, Fernandez-Herrera J, Fraga J, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol. 2005;141:834–42.

    Article  PubMed  Google Scholar 

  37. Ghoufi L, Ortonne N, Ingen-Housz-Oro S, Barhoumi W, Begon E, Haioun C, et al. Histiocytoid Sweet syndrome is more frequently associated with myelodysplastic syndromes than the classical neutrophilic variant. Medicine. 2016;95:e3033.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Peroni A, Colato C, Schena D, Rongioletti F, Girolomoni G. Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol. 2015;72:131–9.

    Article  CAS  PubMed  Google Scholar 

  39. Alegria-Landa V, Rodriguez-Pinilla SM, Santos-Briz A, Rodriguez-Peralto JL, Alegre V, Cerroni L, et al. Clinicopathologic, immunohistochemical, and molecular features of histiocytoid Sweet syndrome. JAMA Dermatol. 2017;153(7):651–9.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Duguid CM, Powell FC. Pyoderma gangrenosum. Clin Dermatol. 1993;11:129–33.

    Article  CAS  PubMed  Google Scholar 

  41. Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patients characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165:1244–50.

    Article  CAS  PubMed  Google Scholar 

  42. Vacas A, Torre AC, Bollea-Garlatti ML, Warley F, Galimberti RL. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients. Int J Dermatol. 2017;56:386–91.

    Article  PubMed  Google Scholar 

  43. Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol. 1983;119:468–72.

    Article  CAS  PubMed  Google Scholar 

  44. DeFilippis EM, Feldman SR, Huang WW. The genetics of pyoderma gangrenosum and implications for treatment: a systematic review. Br J Dermatol. 2015;172:1487–97.

    Article  CAS  PubMed  Google Scholar 

  45. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79:37–46.

    Article  CAS  Google Scholar 

  46. Gade M, Studstrup F, Andersen AK, Hilberg O, Fogh C, Bendstrup E. Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature. Respir Med. 2015;109:443–50.

    Article  PubMed  Google Scholar 

  47. Hensley CD, Caughman SW. Neutrophilic dermatoses associated with hematologic disorders. Clin Dermatol. 2000;18:355–67.

    Article  CAS  PubMed  Google Scholar 

  48. Gibson LE, El-Azhari RA. Erythema elevatum diutinum. Clin Dermatol. 2000;18:295–9.

    Article  CAS  PubMed  Google Scholar 

  49. Momen SE, Jorizzo J, Al-Niaimi F. Erythema elevatum diutinum: a review of presentation and treatment. J Eur Acad Dermatol Venereol. 2014;28:1594–602.

    Article  CAS  PubMed  Google Scholar 

  50. Yiannias JA, El-Azhari RA, Gibson LE. Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients. J Am Acad Dermatol. 1992;26:38–44.

    Article  CAS  PubMed  Google Scholar 

  51. Watts PJ, Khachemoune A. Subcorneal pustular dermatosis: a review of 30 years of progress. Am J Clin Dermatol. 2016;17:653–71.

    Article  PubMed  Google Scholar 

  52. Lutz ME, Daoud MS, MT ME, Gibson LE. Subcorneal pustular dermatosis: a clinical study of ten patients. Cutis. 1998;61:203–8.

    CAS  PubMed  Google Scholar 

  53. Bauwens M, De Coninck A, Roseeuw D. Subcorneal pustular dermatosis treated with PUVA therapy: a case report and review of the literature. Dermatology. 1999;198:203–5.

    Article  CAS  PubMed  Google Scholar 

  54. Copaescu AM, Castilloux JF, Chababi-Atallah M, Sinave C, Bertrand J. A classic clinical case: neutrophilic eccrine hidradenitis. Case Rep Dermatol. 2013;5:340–6.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maxime Battistella .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Battistella, M. (2018). Neutrophilic Dermatoses in Blood Disorders. In: Wallach, D., Vignon-Pennamen, MD., Valerio Marzano, A. (eds) Neutrophilic Dermatoses. Springer, Cham. https://doi.org/10.1007/978-3-319-72649-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72649-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72648-9

  • Online ISBN: 978-3-319-72649-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics